Join ExpreS2ion at BioStock’s Life Science Summit 2025

Meet our CEO, Bent Frandsen, at BioStock’s “Life Science Summit” Summit, taking place on November 12–13, 2025, at KINO (Kyrkogatan 1) in Lund, Sweden. This two-day summit gathers leading investors, biotech executives, and industry experts to explore breakthrough innovations and investment opportunities across the life science value chain.

Bent Frandsen will present ExpreS2ion Biotechnologies on Thursday, November 13, at 14:40 CET, sharing insights into the company’s immunotherapy platform and pipeline, including its HER2-targeted breast cancer vaccine candidate.

The programme offers deep insights into the evolving life science investment landscape, with discussions that resonate strongly with ExpreS2ion’s strategic focus and clinical ambitions. Key highlights include “Women’s Health – Unmet Needs and New Frontiers,” “Deal Ready – The Pharma Partnering Playbook,” and “AI in Healthcare: The Next Frontier.” These sessions, together with company presentations from ExpreS2ion and other Nordic innovators, offer investors a unique window into high-growth biotech opportunities shaping the future of healthcare.

Attendance is invite-only and free of charge, but seats are limited.
Apply for your ticket via the BioStock event page